Filing Details

Accession Number:
0001093557-17-000050
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-08 18:28:52
Reporting Period:
2017-03-06
Filing Date:
2017-03-08
Accepted Time:
2017-03-08 18:28:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1093557 Dexcom Inc DXCM Surgical & Medical Instruments & Apparatus (3841) 330857544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236386 S Jay Skyler 6340 Sequence Drive
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-06 31,890 $7.31 49,136 No 4 M Indirect by Partnership
Common Stock Disposition 2017-03-06 31,890 $78.13 17,246 No 4 S Indirect by Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect by Partnership
No 4 S Indirect by Partnership
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2017-03-06 31,890 $78.13 31,890 $7.31
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-05-23 2017-05-23 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,011 Direct
Common Stock 10,000 Indirect by Spouse
Footnotes
  1. Shares are held by Skyler Bach Family Limited Partnership, LLP, with respect to which the reporting person is a managing partner of the partnership and maintains voting rights of these shares.
  2. This transaction was executed in multiple trades at prices ranging from $78.00 to $78.28. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  3. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.